THE LONG TERM OBJECTIVE OF THIS LINE OF INVESTIGATION IS TO DEVELOP A NEW CLASS OF ANTIVIRALS WHICH ARE EFFECTIVE AGAINST A WIDE VARIETY OF INFECTIONS, ARE SAFE FOR HUMAN USE, ECONOMICAL TO PRODUCE AND ENHANCE RESISTANCE TO OR RECOVERY FROM VIRAL

Award Information
Agency:
Department of Defense
Amount:
$49,700.00
Program:
SBIR
Contract:
N/A
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
Navy
Award Year:
1985
Phase:
Phase I
Agency Tracking Number:
1994
Solicitation Topic Code:
N/A
Small Business Information
Matrix Technologies Inc
2025 Nasa Road 1, Seabrook, TX, 77586
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 DR MICHAEL C TRACHTENBERG
 (713) 333-2982
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE LONG TERM OBJECTIVE OF THIS LINE OF INVESTIGATION IS TO DEVELOP A NEW CLASS OF ANTIVIRALS WHICH ARE EFFECTIVE AGAINST A WIDE VARIETY OF INFECTIONS, ARE SAFE FOR HUMAN USE, ECONOMICAL TO PRODUCE AND ENHANCE RESISTANCE TO OR RECOVERY FROM VIRAL INFECTIOUS AGENTS. THE AGENTS MAY HAVE APPLICATION IN CONJUNCTION WITH KNOWN IMMUNOPOTENTIATORS RECENT EXPERIMENTAL DATA INDICATE THAT A VARIETY OF COMMON ORGANIC AND INORGANIC COMPOUNDS POSSESS DECIDED ANTIVIRAL PROPERTIES AND CONSTITUTE A POTENTIALLY IMPORTANT CLASS OF ANTIVIRAL AGENTS. THE DATA INDICATE THAT THESE AGENTS ARE EFFECTIVE BOTH IN VITRO AND IN VIVO. DURING PHASE I, MATRIX WILL CONDUCT TISSUE CULTURE AND PRELIMINARY INTACT ANIMAL STUDIES OF THE PROPHYLACTIC AND THERAPEUTIC EFFICACY OF FOUR OF THE MOST PROMISING COMPOUNDS AGAINST RESPIRATORY, INFLUENZA AND ENCEPHALITIS VIRUSES.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government